NOVOSIBIRSK, September 24 — RIA Novosti. The development of individualized immunotherapy vaccine against breast cancer won the contest of innovation projects, announced on Saturday at the III International Youth Forum "Interra-2011", in which the competition was held.
"Our vaccine will be made individually for each patient based on his blood immune cells. Due to the introduction of a special genetic makeup we teach blood cells to kill breast cancer cells"- Told RIA Novosti the head of the development team from Novosibirsk company" AvaksisBio "molecular biologist and mathematician Amir Maksyutov.
Today in the world there are no drugs approved for use therapeutic vaccines against cancers of the breast, the scientist said. He also said that the company in the near future "AvaksisBio" is going to try a similar approach for the treatment of a number of other cancers — ovarian, esophageal, stomach, and prostate.
The three best of innovation and investment projects in the competition at the International Forum "Interra-2011" also includes "The production and promotion of a new generation of flame retardant — Fukam" Novosibirsk company "Patriot" and "Development of surveillance sensor-based surround view — 3D EYE» of "AISoftPro", also from Novosibirsk.
Awarding of the finalists was held at the closing ceremony of the three-day forum. For the contest received more than 300 innovative projects from Vladivostok, Moscow, St. Petersburg, Chelyabinsk and other cities of the country.